{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T04:15:40Z","timestamp":1790655340457,"version":"4.1.0"},"reference-count":0,"publisher":"Ivyspring International Publisher","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Theranostics"],"published-print":{"date-parts":[[2025,3,15]]},"DOI":"10.7150\/thno.108705","type":"journal-article","created":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:25:16Z","timestamp":1744187116000},"page":"4147-4174","source":"Crossref","is-referenced-by-count":29,"title":["The role of manganese-based MRI contrast agents for cancer theranostics: Where do we stand in 2025?"],"prefix":"10.7150","volume":"15","author":[{"given":"Lingyan","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shubham","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"4137","container-title":["Theranostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.thno.org\/v15p4147.htm","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:26:00Z","timestamp":1744187160000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.thno.org\/v15p4147.htm"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,15]]},"references-count":0,"journal-issue":{"issue":"9"},"URL":"https:\/\/doi.org\/10.7150\/thno.108705","relation":{},"ISSN":["1838-7640"],"issn-type":[{"value":"1838-7640","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,15]]}}}